3 completed, 1 active not recruiting, 1 not yet recruiting. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Pancoast Syndrome: new trials by email Literature Review of Pancoast Syndrome trials Research Report on Pancoast Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors Carboplatin, Paclitaxel, Nivolumab - NSCLC, Pancoast Tumor | Phase 2 | Active not recruiting | Fundación GECP | 22 | 2023-05-12 | 2026-05-05 |
| Efficacy and Safety of CRT, Durvalumab and Surgery for SST Cisplatin, S1, concurrent radiotherapy - Superior Sulcus Tumor, Non-small Cell Lung Cancer Stage IIB | Phase 3 | Not yet recruiting | National Cancer Center Hospital East | 84 | 2020-09-01 | 2020-07-10 |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors belinostat, 5-Fluorouracil (5-FU) - Tumor | Phase 1 | Completed | Valerio Therapeutics | 35 | 2005-09-01 | 2015-07-08 |
| Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806) mitomycin C, vindesine, cisplatin and radiotherapy - Pulmonary Neoplasm | Phase 2 | Completed | Japan Clinical Oncology Group | 75 | 1999-05-01 | 2016-09-22 |
| Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors Surgery, Chest Irradiation, Cisplatin - Lung Cancer | Phase 2 | Completed | M.D. Anderson Cancer Center | 38 | 1993-10-01 | 2016-06-30 |
Lung Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (2) · Adenosarcoma (1) · Breast Neoplasms (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Small Cell (1) · Carcinosarcoma (1) · Chondrosarcoma (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Facial Neoplasms (1) · Fibrosarcoma (1) · Head and Neck Neoplasms (1) · Hemangiosarcoma (1)
Lung Diseases (5) · Neoplasms by Site (5) · Respiratory Tract Diseases (5) · Respiratory Tract Neoplasms (5) · Thoracic Neoplasms (5) · Neoplasms (4) · Bronchial Neoplasms (2) · Lung Neoplasms (2) · Adenoma (1) · Adnexal Diseases (1) · Breast Diseases (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Colonic Diseases (1) · Digestive System Diseases (1)
Cisplatin (3) · Radiotherapy (2) · Surgical Procedures, Operative (2) · Carboplatin (1) · Etoposide (1) · Fluorouracil (1) · Mitomycin (1) · Nivolumab (1) · Paclitaxel (1) · S 1 (combination) (1) · Vindesine (1) · belinostat (1) · durvalumab (1)
Fundación GECP (1) · Japan Clinical Oncology Group (1) · M.D. Anderson Cancer Center (1) · National Cancer Center Hospital East (1) · Valerio Therapeutics (1)
United States (2) · Japan (1) · Spain (1)
Harubumi Kato, M.D., Ph.D. (1) · Mariano Provencio, MD (1) · Ritsuko Komaki, MD (1)